BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 179 filers reported holding BLUEBIRD BIO INC in Q2 2016. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $483,000 | -12.8% | 5,577 | -7.5% | 0.00% | -25.0% |
| Q3 2019 | $554,000 | +191.6% | 6,030 | +302.8% | 0.00% | +300.0% |
| Q2 2019 | $190,000 | -63.5% | 1,497 | -54.8% | 0.00% | -75.0% |
| Q1 2019 | $521,000 | +242.8% | 3,314 | +115.5% | 0.00% | +300.0% |
| Q4 2018 | $152,000 | -16.5% | 1,538 | +23.4% | 0.00% | -50.0% |
| Q3 2018 | $182,000 | -8.5% | 1,246 | +6.2% | 0.00% | 0.0% |
| Q2 2018 | $199,000 | 0.0% | 1,173 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $199,000 | -6.6% | 1,173 | -2.1% | 0.00% | 0.0% |
| Q4 2017 | $213,000 | +56.6% | 1,198 | +20.8% | 0.00% | +100.0% |
| Q3 2017 | $136,000 | +615.8% | 992 | +454.2% | 0.00% | – |
| Q2 2017 | $19,000 | 0.0% | 179 | -13.1% | 0.00% | – |
| Q1 2017 | $19,000 | +58.3% | 206 | +5.1% | 0.00% | – |
| Q4 2016 | $12,000 | +140.0% | 196 | +145.0% | 0.00% | – |
| Q3 2016 | $5,000 | -44.4% | 80 | -61.9% | 0.00% | – |
| Q2 2016 | $9,000 | -30.8% | 210 | +162.5% | 0.00% | – |
| Q2 2015 | $13,000 | -55.2% | 80 | -66.8% | 0.00% | -100.0% |
| Q1 2015 | $29,000 | +480.0% | 241 | +322.8% | 0.00% | – |
| Q4 2014 | $5,000 | +150.0% | 57 | 0.0% | 0.00% | – |
| Q3 2014 | $2,000 | 0.0% | 57 | 0.0% | 0.00% | – |
| Q2 2014 | $2,000 | – | 57 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 6,335,528 | $40,104,000 | 4.92% |
| qPULA Trading Management LP | 14,344 | $91,000 | 0.80% |
| Frazier Life Sciences Management, L.P. | 1,440,757 | $9,120,000 | 0.70% |
| Ikarian Capital, LLC | 462,628 | $2,928,000 | 0.58% |
| Birchview Capital, LP | 98,000 | $620,000 | 0.44% |
| HealthCor Management, L.P. | 455,000 | $2,880,000 | 0.36% |
| Financial Advocates Investment Management | 45,071 | $3,538,000 | 0.29% |
| PDT Partners, LLC | 262,767 | $1,663,000 | 0.25% |
| Monaco Asset Management SAM | 80,000 | $506,000 | 0.19% |
| Summit X, LLC | 103,424 | $651,000 | 0.19% |